Figure 6
From: Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas
Non-specific factors affecting serum autoantibody levels. (A) Serum FLNC protein concentration levels were measured utilizing the sandwich ELISA to be proved equivalent among low-grade gliomas, high-grade gliomas and normal volunteers. (B) Serum total IgG and (C) ant-GST autoantibody levels were not different among low-grade gliom patients, high-grade glioma patients and normal volunteers.